| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/23/2008 | CN101164617A Combination drug therapy for reducing scar tissue formation |
| 04/23/2008 | CN101164552A Centipede polysaccharide protein anti-tumor capsule and preparation method |
| 04/23/2008 | CN101164544A Helicid powder injection for intravenous drip and preparation method |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN101164542A Use of mometasone furoate for preparing drug |
| 04/23/2008 | CN101164537A High-efficient oral silibinin sustained-release preparation and preparation method thereof |
| 04/23/2008 | CN101164536A Apigenin vesicle preparation and its preparation technology |
| 04/23/2008 | CN101164531A Compressed microparticles for dry injection |
| 04/23/2008 | CN101164530A Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof |
| 04/23/2008 | CN100382803C Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
| 04/23/2008 | CN100382800C Bifendate solid dispersible, and its preparing method and low-release preparation containing same |
| 04/23/2008 | CN100382782C Release-improved pharmaceutical formulation |
| 04/23/2008 | CA2607544A1 A pharmaceutical formulation and its use for the treatment of acquired immune deficiency syndrome (aids) and other aids related diseases and a process for its preparation |
| 04/22/2008 | US7361685 Compounds for use in the treatment of skin conditions |
| 04/22/2008 | US7361676 Solid preparation containing single crystal form |
| 04/22/2008 | US7361373 Carbonized pine cone for treating burns; non-scarring; reduced side effects |
| 04/22/2008 | US7361362 Emulsion composition |
| 04/22/2008 | US7361347 Cytotoxic CD44 antibody immunoconjugates |
| 04/22/2008 | US7361343 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC |
| 04/22/2008 | CA2448864C Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| 04/22/2008 | CA2438213C Modulated release particles for aerosol delivery |
| 04/22/2008 | CA2406042C Apparatus for generating an aerosol |
| 04/22/2008 | CA2353417C Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 04/22/2008 | CA2319433C Targeted delivery of biologically active media |
| 04/22/2008 | CA2280183C Method of treating dry eye disease with purinergic receptor agonists |
| 04/22/2008 | CA2265936C Process for producing a plasma protein-containing medicament |
| 04/22/2008 | CA2261902C Radiolabeled annexin conjugates whith hexose and a chelator |
| 04/22/2008 | CA2259781C Low tack lotion, gels and creams |
| 04/22/2008 | CA2250600C Oral analgesic compositions |
| 04/22/2008 | CA2219065C Ophthalmic carrier solution |
| 04/22/2008 | CA2150642C Tablet, capsule, or granule comprising desogestrel |
| 04/17/2008 | WO2008045904A2 Thermoresponsive, biodegradable, elastomeric material |
| 04/17/2008 | WO2008045604A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/17/2008 | WO2008044798A1 Agent for introducing protein into cell |
| 04/17/2008 | WO2008044784A1 Taste-improving agent and food or drink containing the same |
| 04/17/2008 | WO2008044734A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | WO2008044733A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | WO2008044659A1 Highly absorbable composition for oral administration containing oxidized coenzyme q10 |
| 04/17/2008 | WO2008044630A1 Multilayer microcapsule-containing coating material and article using the same |
| 04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
| 04/17/2008 | WO2008044588A1 Branched starch derivative, process for production thereof, and molded article comprising the branched starch derivative |
| 04/17/2008 | WO2008044336A1 Crystal-containing adhesive preparation |
| 04/17/2008 | WO2008044331A1 Solid preparation comprising ibuprofen and tranexamic acid |
| 04/17/2008 | WO2008043825A2 Pharmaceutical anti-infective composition for inhalation. |
| 04/17/2008 | WO2008043777A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | WO2008043701A1 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers |
| 04/17/2008 | WO2008043601A2 Transdermal therapeutic system with two-phase releasing profile |
| 04/17/2008 | WO2008043396A1 Material, item and products comprising a composition having anti-microbial properties |
| 04/17/2008 | WO2008043366A2 Three-domain compounds for transmembrane delivery |
| 04/17/2008 | WO2008043175A1 SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 04/17/2008 | WO2008043167A1 Pharmaceutical compositions comprising intra- and extra- granular fractions |
| 04/17/2008 | WO2008027793A3 Ophthalmic pharmaceutical compositions and uses thereof |
| 04/17/2008 | WO2008027395A3 Pharmaceutical compositions of benzodiazepines and methods of use thereof |
| 04/17/2008 | WO2008027357A3 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 04/17/2008 | WO2008025856A3 Modified glycoproteins |
| 04/17/2008 | WO2008025848A3 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 04/17/2008 | WO2008006064A3 Biomimetic polymers and uses thereof |
| 04/17/2008 | WO2007134845A3 Olanzapine pharmaceutical composition |
| 04/17/2008 | WO2007124224A3 Method for delivering particulate drugs to tissues |
| 04/17/2008 | WO2007107835A3 Stable liquid formulations of antiepileptic agents |
| 04/17/2008 | WO2007099410A3 Formulations of fispemifene |
| 04/17/2008 | WO2007086911A3 Stable nanoparticle formulations |
| 04/17/2008 | WO2007076062A3 Protein formulations with reduced viscosity and uses thereof |
| 04/17/2008 | WO2007028341A8 Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids |
| 04/17/2008 | US20080091007 Modified cellulose films |
| 04/17/2008 | US20080091006 Nitrate ester cyclodextrin complexes |
| 04/17/2008 | US20080090980 Redispersible powder and its aqueous dispersion, preparation, process and use |
| 04/17/2008 | US20080090899 Application of water and organic solvent soluble ivermectin for topical and oral use |
| 04/17/2008 | US20080090894 Transdermal migraine therapy |
| 04/17/2008 | US20080090754 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; zinc; stabilized against denaturing when in contact with an organic solvent |
| 04/17/2008 | US20080090752 Anti-tumor vasculature effects of human serum albumin derivatives |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089963 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 04/17/2008 | US20080089942 Use of adsorbent carbon microspheres to treat intestinal bacterial infections |
| 04/17/2008 | US20080089939 Dermastick thickened ointment |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089934 Soft capsules, solid dosage forms; heating, hydrating, mixing, solubilizing a high solids, low moisture film-forming mixture to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature, feeding into pump, cooling; thermoreversible gel films |
| 04/17/2008 | US20080089930 Keratin-Based Powders and Hydrogel for Pharmaceutical Applications |
| 04/17/2008 | US20080089928 Liposome drug carriers with ph-sensitivity |
| 04/17/2008 | US20080089924 Metastasis inhibitors; foods |
| 04/17/2008 | US20080089913 Capsule Whose Envelope Is Separately Imperceptible During The Topical Use Thereof |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089898 Immunotoxins directed against CD33 related surface antigens |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089853 Amphoteric Ethyl Methacrylate Copolymers and Use Thereof |
| 04/17/2008 | US20080089839 Preparation of Stable High Concentration Coloidal Metal Particulate System |
| 04/17/2008 | CA2703466A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | CA2666440A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/17/2008 | CA2666058A1 Aqueous liquid preparation comprising gatifloxacin |
| 04/17/2008 | CA2665764A1 Pharmaceutical anti-infective composition for inhalation |
| 04/17/2008 | CA2665604A1 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers |
| 04/17/2008 | CA2665423A1 Methods and compositions with reduced opalescence |
| 04/17/2008 | CA2664826A1 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/16/2008 | EP1911789A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911788A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911494A2 Use of oligosaccharides to stimulate beta-endorphin production |
| 04/16/2008 | EP1911464A1 Gel-type base compound based on essential oil mixtures for dermal and transdermal application |
| 04/16/2008 | EP1911463A1 Weight management system for obese animals |
| 04/16/2008 | EP1911462A2 Compositions comprising a sterol absorption inhibitor |